Massive delayed hemolysis following peripheral blood stem cell transplantation with minor ABO incompatibility

Hematology and Cell Therapy

Volumn 39, Issue 3, 1997, Pages 159-162

  Laurencet, F M ^a,b   Samii, K ^a   Bressoud, A ^a   Tajeddin, M ^a   Easton, J ^a   Stelling, M J ^a   Chapuis, B ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Hôpital Cantonal   (Switzerland)

Author keywords

ABO incompatibility; Bone marrow transplantation; Hemolysis

Indexed keywords

CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE;

ADULT; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CASE REPORT; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; HEMOLYSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MULTIPLE MYELOMA; STEM CELL TRANSPLANTATION;

ABO BLOOD-GROUP SYSTEM; ADULT; ANEMIA, HEMOLYTIC; BLOOD GROUP INCOMPATIBILITY; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOLYSIS; HUMANS; MALE;

EID: 0030740228     PISSN: 12693286     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00282-997-0159-4     Document Type: Article

References (23)

1. Gajewski JL, Petz LD, Calhoun L, et al (1992) Hemolysis of transfused group O red blood cells in minor ABO-incompatible unrelateddonor bone marrow transplants in patients receiving cyclosporine without posttransplant methotrexate. Blood 79: 3076-3085
2. Greeno EW, Perry EH, Ilstrup SJ, et al (1996) Exchange transfusion the hard way: massive hemolysis following transplantation of bone marrow with minor ABO incompatibility. Transfusion 36: 71-74
3. Hale G, Swirsky D, Waldmann H, et al (1985) Reactivity of rat monoclonal antibody Campath-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation. Br J Haematol 60: 41-48
4. Hale G, Waldmann H (1994) CAMPATH-1 monoclonal antibodies in bone marrow transplantation. J Hematother 3: 15-31
5. Hazlehurst GR, Brenner MK, Wimperis JZ, et al (1986) Haemolysis after T-cell depleted bone marrow transplantation involving minor ABO incompatibility. Scand J Haematol 37: 1-3
6. Hows J, Beddow K, Gordon-Smith E, et al (1986) Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood 67: 177-181
7. Hunt BJ, Yacoub M, Amin S, et al (1988) Induction of red blood cell destruction by graft-derived antibodies after minor ABO-mismatched heart and lung transplantation. Transplantation 46: 246-249
8. Hyma BA, Moore SB, Grande JP, et al (1988) Delayed immune hemolysis in a patient receiving cyclosporine after orthotopic liver transplantation. Transfusion 28: 276-279
9. dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease. Blood 86: 2842-2848
10. Lane TA, Law P, Maruyama M, et al (1995) Harvesting and enrichment of hematopoietic progenitor cells mobilized into the peripheral blood of normal donors by granulocyte-macrophage colony-stimulating factor (GM-CSF) or G-CSF: potential role in allogeneic marrow transplantation. Blood 85: 275-282
11. Maeda K, Taniwaki K, Santo T, et al (1995) Anti-A and/or anti-B is not detectable in some patients who underwent ABO-incompatible bone marrow transplantation. Transfusion 35: 635-639
12. Mizon P, Jouet JP, Vanhaesbroucke C, et al (1994) Surveillance immunohématologique de patients traités par allogreffes de moelle osseuse ABO incompatibles. Transfus Clin Biol 4: 271-277
13. Orchard J, Young NT, Smith C, et al (1990) Severe intravascular haemolysis in a renal transplant recipient due to anti-B of donor origin. Vox Sang 59: 172-175
14. Pan L, Delmonte J Jr, Jalonen CK, et al (1995) Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 86: 4422-4429
15. Ramsey G, Nasbacher J, Starzl TE, et al (1984) Isohemagglutinin of graft origin after ABO-unmatched liver transplantation. N Engl J Med 311: 1167-1170
16. Ramsey G (1991) Red cell antibodies arising from solid organ transplants. Transplantation 31: 76-86
17. Rieben R, Tucci A, Nydegger UE, et al (1992) Self tolerance to human A and B histo-blood group antigens exists at the B cell level and cannot be broken by potent polyclonal B cell activation in vitro. Eur J Immunol 22: 2713-2717
18. Roux E, Helg C, Chapuis B, et al (1992) Evolution of mixed chimerism after allogeneic bone marrow transplantation as determined on granulocytes and mononuclear cells by the polymerase chain reaction. Blood 79: 2775-2783
19. Solheim BG, Albrechtsen DA, Berg KJ, et al (1987) Hemolytic anemia in cyclosporine-treated recipients of kidney or heart grafts from donors with minor incompatibility for ABO antigens. Transplant Proc XIX: 4236-4238
20. Swanson J, Sehring E, Sastamoinen R, et al (1991) Gm allotyping to determine the origin of the anti-D causing hemolytic anemia in a kidney transplant recipient. Vox Sang 52: 228-230
21. Toren A, Dacosta Y, Mann N, et al (1996) Passenger B-lymphocyte-induced severe hemolytic disease after allogeneic peripheral blood stem cell transplantation. Letter to the editor. Blood 87: 843-844
22. Verbik DJ, Jackson JD, Pirruccello SJ, et al (1995) Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. Blood 85: 1964-1970
23. Wernet D, Mayer G (1992) Isoagglutinins following ABO-incompatible bone marrow transplantation. Vox Sang 62: 176-179